Search results
Results from the WOW.Com Content Network
Mendelson's syndrome, named in 1946 for American obstetrician and cardiologist Curtis Lester Mendelson, is a form of chemical pneumonitis or aspiration pneumonitis caused by aspiration of stomach contents (principally gastric acid) during anaesthesia in childbirth.
Mendelson's syndrome is a type of chemical pneumonitis. Mineral oil should not be given internally to young children, pets, or anyone with a cough, hiatal hernia, or nocturnal reflux, because it can cause complications such as lipoid pneumonia. [3] Due to its low density, it is easily aspirated into the lungs, where it cannot be removed by the ...
Curtis Lester Mendelson (September 4, 1913 - October 13, 2002) was an obstetrician and American cardiologist. Mendelson's syndrome was named after him in 1946. [ 1 ] [ 2 ]
The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation.
Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin, the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process.
In 1986 Poser tried to restrict the use of Schilder's disease name to the disease described here, but this name has still remained ambiguous. [citation needed] The name comes from a traditional classification of demyelinating diseases in two groups: demyelinating myelinoclastic diseases and demyelinating leukodystrophic diseases. In the first ...
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. Trial ...
Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. [8] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. [10] Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. [10]